David Nathanson

About David Nathanson

David Nathanson, With an exceptional h-index of 32 and a recent h-index of 25 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of Cancer Biology, Brain Cancer, Drug Development.

His recent articles reflect a diverse array of research interests and contributions to the field:

Basal BCL-2-Interacting Mediator of Cell Death (BIM) Responsiveness Correlates with Radiosensitivity in Meningioma

PDXpower: A Power Analysis Tool for Experimental Design in Pre-clinical Xenograft Studies for Uncensored and Censored Outcomes

D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation

Compositions and methods for treating cancer

Combination Therapy with Mtor Inhibition and Ionizing Radiation in Meningioma Results In Superior Cytostatic Effect than Monotherapy

Cover Image, Volume 36, Issue 6

Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma

CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

David Nathanson Information

University

Position

___

Citations(all)

5126

Citations(since 2020)

3416

Cited By

2831

hIndex(all)

32

hIndex(since 2020)

25

i10Index(all)

46

i10Index(since 2020)

44

Email

University Profile Page

Google Scholar

David Nathanson Skills & Research Interests

Cancer Biology

Brain Cancer

Drug Development

Top articles of David Nathanson

Title

Journal

Author(s)

Publication Date

Basal BCL-2-Interacting Mediator of Cell Death (BIM) Responsiveness Correlates with Radiosensitivity in Meningioma

Journal of Neurological Surgery Part B: Skull Base

Maya Harary

Elizabeth Fernandez

Joshua Casaos

Jeremie Vitte

David Nathanson

...

2024/2

PDXpower: A Power Analysis Tool for Experimental Design in Pre-clinical Xenograft Studies for Uncensored and Censored Outcomes

arXiv preprint arXiv:2404.08927

Shanpeng Li

Donatello Telesca

Harley I Kornblum

David Nathanson

Frank Pajonk

...

2024/4/13

D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation

Cancer Research Communications

Sean T Pianka

Tie Li

Terry J Prins

Blaine SC Eldred

Bryan M Kevan

...

2024/3/22

Compositions and methods for treating cancer

2014/6/12

Combination Therapy with Mtor Inhibition and Ionizing Radiation in Meningioma Results In Superior Cytostatic Effect than Monotherapy

Journal of Neurological Surgery Part B: Skull Base

Maya Harary

Elizabeth Fernandez

Joshua Casaos

Jeremie Vitte

David Nathanson

...

2024/2

Cover Image, Volume 36, Issue 6

NMR in Biomedicine

Nicholas S Cho

Akifumi Hagiwara

Jingwen Yao

David A Nathanson

Robert M Prins

...

2023/6

Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma

Clinical Cancer Research

Benjamin M Ellingson

Akifumi Hagiwara

Connor J Morris

Nicholas S Cho

Sonoko Oshima

...

2023/10/13

CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

Cancer cell

Jenna K Minami

Danielle Morrow

Nicholas A Bayley

Elizabeth G Fernandez

Jennifer J Salinas

...

2023/6/12

Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma

Neuro-oncology

Benjamin Lin

Julia Ziebro

Erin Smithberger

Kasey R Skinner

Eva Zhao

...

2023/1

Amine‐weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors

NMR in Biomedicine

Nicholas S Cho

Akifumi Hagiwara

Jingwen Yao

David A Nathanson

Robert M Prins

...

2023/6

Calculation of ATP production rates using the Seahorse XF Analyzer

EMBO reports

Brandon R Desousa

Kristen KO Kim

Anthony E Jones

Andréa B Ball

Wei Y Hsieh

...

2023/10/9

Non-invasive functional companion assays for oncogene targeted therapy for brain cancer

2023/11/9

PKM2 rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance.

Justine Bailleul

Yangjingyi Ruan

Lobna Abdulrahman

Andrew J Scott

Taha Yazal

...

2023/6/5

Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis

Immunology

Bao Ying Chen

Jessica R Salas

Alyssa O Trias

Arely Perez Rodriguez

Jonathan E Tsang

...

2023/1/1

Targeting the intrinsic apoptotic machinery in glioblastoma

2023/2/9

MODL-05. ELUCIDATING THE EPIGENETIC DRIVEN TRANSCRIPTIONAL PROGRAM UNDERLYING THE INVASIVE PHENOTYPE OF THE NOVEL EGFRA289VARIANT OF GBM

Neuro-Oncology

Benjamin Lin

Julia Ziebro

Abigail Shelton

Kasey Skinner

Ryan Bash

...

2023/11/1

Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus

Cells

Gustavo Garcia Jr

Nikhil Chakravarty

Sophia Paiola

Estrella Urena

Priya Gyani

...

2023/9/29

DIPG-56. PEDIATRIC GLIOMAS EXHIBIT A UNIQUE LIPID METABOLIC PHENOTYPE DISTINCT FROM ADULT GBMS

Neuro-Oncology

Jennifer Salinas

Jenna Minami

Nicholas Bayley

Christopher Tse

Henan Zhu

...

2023/6

Functional Classification of Apoptotic Sensitivity in Meningioma

Journal of Neurological Surgery Part B: Skull Base

Maya Harary

Elizabeth Fernandez

Joshua Casaos

Jeremie Vitte

David Nathanson

...

2023/2

1491 Aberrant EGFR activation drives enhanced infiltration of immunosuppressive microglia and macrophages in the glioblastoma tumor immune microenvironment

Marissa S Pioso

Katie B Grausam

Marissa Li

Joshua J Breunig

David A Nathanson

...

2023/11/1

See List of Professors in David Nathanson University(University of California, Los Angeles)